- Addus HomeCare reported Q3 2026 net income of US$28.59 million versus US$22.85 million a year earlier, with diluted EPS from continuing operations of US$1.54 compared with US$1.24.
- Over the first nine months of 2026, Addus HomeCare’s net income reached US$81.27 million and diluted EPS from continuing operations was US$4.39, illustrating how earnings performance relates to execution in personal care, hospice, and home health services.
- The focus now turns to how Addus HomeCare’s stronger earnings per share profile could influence the existing investment narrative around margin resilience.
Scan how Addus HomeCare’s latest earnings compare with peers by reviewing it alongside list of solid balance sheet and fundamentals (23 results), which also features companies with consistent profitability and strong financial positions.
Addus HomeCare Investment Narrative Recap
To own Addus HomeCare, you need to believe in steady demand for home based care and the company’s ability to keep execution tight while reimbursement, wages and taxes stay in focus. The latest Q3 and year to date earnings show that the current operating model in personal care, hospice and home health is translating into higher net income and EPS.
For the near term, the key swing factor is whether state rate actions and operational tools like the caregiver app continue to offset labor cost and tax headwinds. The major operational risk remains caregiver availability and wage pressure, which could compress margins if staffing costs climb faster than reimbursement.
The most relevant datapoint right now is the Q3 2026 report itself, because it updates how Addus HomeCare is handling these pressures. Net income of US$28.59 million for the quarter and US$81.27 million for the first nine months, together with higher diluted EPS than a year ago, provides a clearer view of ongoing execution.
Those figures sit alongside earlier expectations for mid single digit organic personal care momentum, reimbursement changes in states like Illinois and Texas, and the planned AccentCare personal care acquisition. Taken together, the current earnings run rate becomes the reference point for judging whether future reimbursement, labor costs and acquisition integration shift the risk reward balance.
Addus HomeCare’s analyst narrative points to forecast revenue of US$1.7b and earnings of US$142.6 million by 2029, based on an assumed 5.2% yearly increase in revenue and a move in earnings from US$105.3 million today. This implies an earnings rise of about US$37 million over the period.
Uncover how Addus HomeCare's fair value indicates a 6% potential upside to its current price that may not last much longer.
Exploring Other Perspectives
Some of the most optimistic analysts focus on the AccentCare acquisition as the real swing factor for Addus HomeCare, not just current Q3 earnings. Before this report, the bullish camp was modeling about US$1.8b of revenue and US$158.7 million of earnings by 2029. That is a much richer story than consensus, and this latest update could push those views to shift again.
Explore 3 other Addus HomeCare fair value estimates, including one that suggests up to 71% upside from the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider trusting your own research and judgment.
- A great starting point for your Addus HomeCare research is our analysis highlighting 4 key rewards that could impact your investment decision.
- See our latest analysis for Addus HomeCare. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Addus HomeCare's overall financial health at a glance.
Looking For More Investment Ideas Beyond Addus HomeCare?
Once you have weighed up the Addus HomeCare story, it can help to compare it with a broader set of businesses that fit clear financial themes using the Simply Wall St Screener.
- If you want potential value combined with quality fundamentals, start by reviewing our 35 high quality undervalued stocks, which already meet strict balance sheet and earnings filters.
- For income focused investing, assess companies in the 4 dividend fortresses that pair higher yields with resilient cash generation.
- If capital preservation matters most, narrow your search to the 30 resilient stocks with low risk scores, which screen well on volatility, debt, and business risk.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com